7. RISK FACTORS STUDY OF SEVERE ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT BINH DINH TUBERCULOSIS AND LUNG DISEASE HOSPITAL IN 2023

Huynh Dinh Nghia1
1 Binh Dinh Tuberculosis and Lung Disease Hospital

Main Article Content

Abstract

Objective: The present study intended to determine the risk factors of severe exacerbation in chronic obstructive pulmonary disease patients and correlation factors.


Material and Method: A descriptive study was conducted at the Binh Dinh Tuberculosis and Lung disease Hospital from March 2022 to September 2023. The clinical and paraclinical relevant data for acute exacerbation (age, sex, Smoking status, BMI, Disease duration , Acute attack per year, co-morbidity, severity of COPD, COPD medication, annual influenza vaccination, compliance with inhaled drug use, chest radiographic abnormality,white blood cells, Neutrophile/ lymphocyte ratio,C reaction Protein, sputum culture) were compared between severe AECOPD and mild- moderate AECOPD patients by logistic regression analysis.


Results: Out of 140 AECOPD patients, 112 (80%) had severe AECOPD. The eleven risk factors BMI underweight (OR: 3.92 95% CI 1.59 – 9.66);Smoking > 20 packs-year (OR 3.32 95% CI 1.35- 8.45); Disease duration > 5 years ( OR 23.56 95% CI 7.75 – 71.6); hypertension ( OR 2.75 95% CI 1.04 – 7.31); chronic kidney disease (OR 9.88 95% CI 1.29 – 75.91);improper use of inhaled devices (OR 3.50 95% CI1.68 – 9.23); Influenza non-vaccination (OR 5.47 95% CI2.6- 38.4) white blood cells > 10 Giga/L( OR 9.40 95% CI 3.74 – 23.66); Neutrophil/Lymphocyte ratio >4 (OR 2.58 95% CI 1.09 – 6.10); emphysema ( OR 4.09 95% CI 1.09- 6.10);sputum culture positive ( OR 11.77 95% CI 4.54 – 30.54).There were positive correlation between CRP and white blood cell count, CRP and N/L ratio.


Conclusion: Eleven risk factors of severe AECOPD among patients

Article Details

References

[1] Global Initiative for Chronic Obstructive Lung
Disease (GOLD 2020).
[2] Jiang J, Jhao J et al., Risk factors associated
with acute exacerbation of chronic obstructive
pulmonary disease: A retrospective analysis in
4624 patients, Biomedical Research, 2017, 28
(9): 3855-3859.
[3] Chaicharn P, Thatawan P, Chalerm L et al., Risk
Factors of Severe Acute Exacerbation of Chronic
Obstructive Pulmonary Disease Among Patients
Regularly Managed by Pulmonologists, J Med
Assoc Thai; 2017, 100 (2): 142-148.
[4] Mohapatra PR, Janmeja AK, Factors Associated
with Hospital Admission in Patients with Acute
Exacerbation of Chronic Obstructive Pulmonary
Disease, The Indian Journal of Chest Diseases &
Allied Sciences, 2010, Vol 52, 203-206.
[5] Songsong Y, Qiuhong F, Yinjuan L, Independent
factors associated with pneumonia among
hospitalized patients with acute exacerbations
of chronic obstructive pulmonary disease,
Medicine, 2018, 1-6.
[6] Jacques P, Jean-Michel C, Philippe D et al.,
High-risk patients following hospitalisation for an
acute exacerbation of COPD, Eur Respir J, 2013,
42: 946–955
[7] Miguel G, Xavier P, Silvia C et al, C-reactive
protein in outpatients with acute exacerbation of
COPD: its relationship with microbial etiology and
severity, International Journal of COPD: 11, 2016.
[8] Ahmet B, Munire G, Ozkan K et al., C-Reactive
Protein Levels in Patients with Chronic Obstructive
Pulmonary Disease: Role of Infection, Med Princ
Pract, 2008; 17:202–208.
[9] Yanyan L, Linlin X, Shuzhen X et al., Values of
procalcitonin and C-reactive proteins in the
diagnosis and treatment of chronic obstructive
pulmonary disease having concomitant bacterial
infection, Pak J Med Sci, 2017, Vol. 33 No 3.
[10] MiLacic N et al., Correlation of c-reactive protein
and copd severity, Acta Clin Croat, Vol. 55, No.1, 2016.